New Delhi: Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator for its generic version of ascorbic acid injection used for short-term treatment of scurvy.
The final approval by the US Food and Drug Administration (USFDA) is for the Abbreviated New Drug Application (ANDA) for ascorbic acid injection of strengths 25,000 mg/50 mL (500 mg/mL), 5,000 mg/10 mL (500 mg/mL), Zydus Lifesciences Ltd said in a regulatory filing.
